Skip to main content
Clinical Trials/NL-OMON25983
NL-OMON25983
Recruiting
Not Applicable

Efficacy of Sodium Oxybate to promote sleep in the ICU: A randomized controlled trial

eiden University Medical Center0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep disruption in the IC
Sponsor
eiden University Medical Center
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Admission to the ICU/MCU;
  • Expected duration of ICU/MCU admission \> 2 nights after detection of sleep difficulties;
  • Awake, conscious (patients can be intubated);
  • RASS (Richmond Agitation\-Sedation Scale) score \= \-2;
  • The patient is experiencing sleep difficulties based on their own or clinical judgment as well as on a low score (\<60% average score) on the Richard Campbell Sleep Questionnaire;
  • The ICU physician intends to prescribe general sleep promoting measures as well as a benzodiazepine because of the sleep problems.

Exclusion Criteria

  • Use of sedatives for sleep problems (for example benzodiazepine use) in the last 3 days, except a low dose of Sufentanil (up to 2,5 µg/hr) in intubated patients since this dose is frequently needed to counteract laryngeal tube irritation;
  • Current use of haloperidol, except a maintenance dose in patients recovering from a delirium;
  • RASS score \< \-2;
  • Active delirium, as assessed by a ICDSC\-NL score \> 3;
  • SSADH\-deficiency;
  • Severe depression;
  • Planned ICU admission time \< 3 nights after detection of sleep difficulties.

Outcomes

Primary Outcomes

Not specified

Similar Trials